Shu-Jen Chen
Company: AnHorn Medicines
Job title: Chief Scientific Officer
Seminars:
Discovering New Moieties to Recruit Other E3 Ubiquitin Ligases 4:10 pm
• Sharing AI-enhanced discovery pipeline for targeted protein degradation • Discussing development of a first-in-class androgen receptor (AR) degrader • Updating on exclusive pipeline for the discovery of molecular gluesRead more
day: Conference Day 1